Hyperion DeFi, Inc. (NASDAQ:HYPD – Get Free Report) insider Hyunsu Jung bought 7,000 shares of Hyperion DeFi stock in a transaction on Monday, June 1st. The shares were bought at an average cost of $3.70 per share, with a total value of $25,900.00. Following the acquisition, the insider directly owned 1,384,676 shares in the company, valued at approximately $5,123,301.20. This represents a 0.51% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Hyunsu Jung also recently made the following trade(s):
- On Tuesday, June 2nd, Hyunsu Jung bought 1,000 shares of Hyperion DeFi stock. The shares were bought at an average cost of $3.66 per share, with a total value of $3,660.00.
Hyperion DeFi Stock Down 3.0%
HYPD stock opened at $3.50 on Friday. The company has a quick ratio of 1.97, a current ratio of 1.97 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $53.06 million, a PE ratio of -0.35 and a beta of 2.47. Hyperion DeFi, Inc. has a twelve month low of $2.11 and a twelve month high of $17.18. The stock has a 50-day simple moving average of $3.66 and a two-hundred day simple moving average of $3.63.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of HYPD. Renaissance Technologies LLC purchased a new position in shares of Hyperion DeFi during the fourth quarter worth about $663,000. Jane Street Group LLC purchased a new position in shares of Hyperion DeFi during the fourth quarter worth about $493,000. Focus Partners Advisor Solutions LLC purchased a new position in shares of Hyperion DeFi during the fourth quarter worth about $221,000. Geode Capital Management LLC purchased a new position in shares of Hyperion DeFi during the fourth quarter worth about $214,000. Finally, Investment House LLC purchased a new position in shares of Hyperion DeFi during the fourth quarter worth about $166,000. Hedge funds and other institutional investors own 25.84% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on HYPD. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Hyperion DeFi in a report on Wednesday, May 20th. Zacks Research lowered Hyperion DeFi from a “hold” rating to a “strong sell” rating in a report on Monday, March 30th. Finally, Cantor Fitzgerald raised Hyperion DeFi to a “strong-buy” rating in a report on Thursday, April 9th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $5.88.
Get Our Latest Research Report on HYPD
About Hyperion DeFi
Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.
See Also
- Five stocks we like better than Hyperion DeFi
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Hyperion DeFi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperion DeFi and related companies with MarketBeat.com's FREE daily email newsletter.
